The effects of Gender-Affirming Hormone Therapy (GAHT) on blood pressure of transgender adolescents as measured by ambulatory blood pressure monitoring (ABPM) over the first year of therapy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Hypertension
Gender Identity Disorder
Age: Between 14 Year(s) - 23 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Between the ages of 14-23 years old
2. Patients with plans to receive gender-affirming hormonal therapy (either exogenous testosterone or estrogen)
3. Behaviorally able to wear a 24-hour ambulatory blood pressure monitor

You may not be eligible for this study if the following are true:

1. Initiation of gender-affirming hormonal therapy (i.e. exogenous testosterone or estrogen) prior to recruitment
2. Puberty-blockers as sole GAHT
3. Pre-existing diagnosis of hypertension

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies